Literature DB >> 539793

A simple robust assay for testosterone in male plasma using an 125I-radioligand and a solid-phase separation technique.

J Dyas, G F Read, D Riad-Fahmy.   

Abstract

A radioimmunoassay for testosterone in male plasma utilising a gamma-emitting radioligand and a solid-phase antiserum is described. The radioligand is testosterone-3-(O-carboxymethyl)-oxime coupled to 125I-iodohistamine, and the solid-phase antiserum is prepared by coupling antitestosterone-3-bovine serum albumin to cyanogen bromide activated cellulose. The new procedure retains much of the specificity associated with a published, specific radioimmunoassay using an antiserum raised against testosterone-11 alpha-BSA and a tritium radioligand and incorporating a dextra-coated charcoal separation procedure; values obtained by the two procedures are in excellent agreement (r = 0.98, n = 20). The combination of an 125I-radioligand and a solid-phase separation technique greatly increases sample throughput and has the further advantage of reduced running costs and a greater potential for automation. The method gives satisfactory levels of sensitivity, precision, and accuracy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 539793     DOI: 10.1177/000456327901600186

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  10 in total

1.  Response to treatment of congenital adrenal hyperplasia in infancy.

Authors:  M C Young; I A Hughes
Journal:  Arch Dis Child       Date:  1990-04       Impact factor: 3.791

2.  Human hepatocellular carcinoma tumor xenografts. Their androgen-receptor status and growth responses to castration.

Authors:  A A Dunk; N Kyprianou; P Davies; H C Thomas
Journal:  Dig Dis Sci       Date:  1988-04       Impact factor: 3.199

3.  The effect of chronic propranolol treatment on overnight plasma levels of anterior pituitary and related hormones.

Authors:  A M Dart; M J Lewis; G V Groom; E M Meek; A H Henderson
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

4.  The effect of orally administered cadmium on the ultrastructure of the rat prostate.

Authors:  S Battersby; J A Chandler; M S Morton
Journal:  Urol Res       Date:  1982

5.  Normal postnatal androgen production and action in isolated micropenis and isolated hypospadias.

Authors:  B A Evans; D M Williams; I A Hughes
Journal:  Arch Dis Child       Date:  1991-09       Impact factor: 3.791

6.  Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.

Authors:  J A Tobert; G D Bell; J Birtwell; I James; W R Kukovetz; J S Pryor; A Buntinx; I B Holmes; Y S Chao; J A Bolognese
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

7.  The effects of propranolol and acebutolol on the overnight plasma levels of anterior pituitary and related hormones.

Authors:  M J Lewis; G V Groom; R Barber; A H Henderson
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

8.  Androstenedione rhythms in saliva in congenital adrenal hyperplasia.

Authors:  M C Young; R F Walker; D Riad-Fahmy; I A Hughes
Journal:  Arch Dis Child       Date:  1988-06       Impact factor: 3.791

9.  Does the serum testosterone level have a relation to coronary artery disease in elderly men?

Authors:  Mohamed A Helaly; Eid Daoud; Noha El-Mashad
Journal:  Curr Gerontol Geriatr Res       Date:  2011-05-23

10.  Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630.

Authors:  P N Plowman; R I Nicholson; K J Walker
Journal:  Br J Cancer       Date:  1986-12       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.